Frontiers in Cell and Developmental Biology, 2022 · DOI: 10.3389/fcell.2022.824036 · Published: March 8, 2022
The ability to regenerate nerve tissues varies greatly across different animal species. Some animals, like lampreys and zebrafish, can regenerate their nervous systems after injury, while mammals have limited capacity. By studying the molecular mechanisms behind nerve regeneration in different species, we can identify key factors that promote successful regeneration. Activating transcription factor 3 (ATF3) is one such factor that appears to be conserved across vertebrates. ATF3 is rapidly induced in neurons after nerve injury in multiple species and promotes axon regrowth and regeneration. By studying ATF3, we can better understand the molecular basis of vertebrate CNS regeneration and develop therapeutic strategies for spinal cord injury. This review summarizes the current evidence for ATF3 as a conserved pro-regenerative factor. It explores how ATF3 works with other regeneration-associated genes (RAGs) to activate gene transcription, leading to axonal regrowth. It also discusses the potential of ATF3 as a therapeutic strategy for promoting CNS regeneration after traumatic spinal cord injury (SCI).
ATF3 could be a potential therapeutic target for promoting CNS regeneration after traumatic spinal cord injury.
Identifying downstream effectors of ATF3 will be a critical next step in understanding the molecular basis of vertebrate CNS regeneration.
The pre-dimerized cJUN-ATF3 complex may be a viable tool for promoting neural regeneration that could be developed further for preclinical testing.